Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis
Johannes Brettschneider, David J. Libon, Jon B. Toledo, Sharon X. Xie, Leo McCluskey, Lauren Elman, Felix Geser, Virginia M. -Y. Lee, Murray Grossman and John Q. Trojanowski
While cognitive deficits are increasingly recognized as common symptoms in amyotrophic lateral sclerosis (ALS), the underlying histopathologic basis for this is not known, nor has the relevance of neuroinflammatory mechanisms and microglial activation to cognitive impairment (CI) in ALS been systematically analyzed. Staining for neurodegenerative disease pathology, TDP-43, and microglial activation markers (CD68, Iba1) was performed in 102 autopsy cases of ALS, and neuropathology data were related to clinical and neuropsychological measures. ALS with dementia (ALS-D) and ALS with impaired executive function (ALS-Ex) patients showed significant microglial activation in middle frontal and superior or middle temporal (SMT) gyrus regions, as well as significant neuronal loss and TDP-43 pathology in these regions. Microglial activation and TDP-43 pathology in middle frontal and superior or middle temporal regions were highly correlated with measures of executive impairment, but not with the MMSE. In contrast, only one ALS-D patient showed moderate Alzheimer's disease (AD) pathology. Tau and A beta pathology increased with age. A lower MMSE score correlated with tau pathology in hippocampus and SMT gyrus, and with A beta pathology in limbic and most cortical regions. Tau and A beta pathology did not correlate with executive measures. We conclude that microglial activation and TDP-43 pathology in frontotemporal areas are determinants of FTLD spectrum dementia in ALS and correlate with neuropsychological measures of executive dysfunction. In contrast, AD pathology in ALS is primarily related to increasing age and associated with a poorer performance on the MMSE.
Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis
Creators
Johannes Brettschneider - University of Pennsylvania
David J. Libon - Drexel University
Jon B. Toledo - University of Pennsylvania
Sharon X. Xie - University of Pennsylvania
Leo McCluskey - University of Pennsylvania
Lauren Elman - University of Pennsylvania
Felix Geser - Universität Ulm
Virginia M. -Y. Lee - College Station Medical Center
Murray Grossman - University of Pennsylvania
John Q. Trojanowski - University of Pennsylvania
Publication Details
Acta neuropathologica, v 123(3), pp 395-407
Publisher
Springer Nature
Number of pages
13
Grant note
AG033101; AG17586; AG10124; AG32953 / NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
Wyncote Foundation
Fundacion Alfonso Martin Escudero
P01AG032953 / NATIONAL INSTITUTE ON AGING; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)
AOBJ586910 / Deutsche Forschungsgemeinschaft DFG; German Research Foundation (DFG)
Koller Family Foundation
Resource Type
Journal article
Language
English
Web of Science ID
WOS:000301856300006
Scopus ID
2-s2.0-84857918252
Other Identifier
991021901314404721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: